Skip to search boxSkip to navigationSkip to main content

Sigma 1 receptor activation improves retinal structure and function in the RhoP23H/+ mouse model of autosomal dominant retinitis pigmentosa

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

Retinitis pigmentosa (RP) is a group of devastating inherited retinal diseases that leads to visual impairment and oftentimes complete blindness. Currently no cure exists for RP thus research into prolonging vision is imperative. Sigma 1 receptor (Sig1R) is a promising small molecule target that has neuroprotective benefits in retinas of rapidly-degenerating mouse models. It is not clear whether Sig1R activation can provide similar neuroprotective benefits in more slowly-progressing RP models. Here, we examined Sig1R-mediated effects in the slowly-progressing RhoP23H/+ mouse, a model of autosomal dominant RP. We characterized the retinal degeneration of the RhoP23H/+ mouse over a 10 month period using three in vivo methods: Optomotor Response (OMR), Electroretinogram (ERG), and Spectral Domain-Optical Coherence Tomography (SD-OCT). A slow retinal degeneration was observed in both male and female RhoP23H/+ mice when compared to wild type. The OMR, which reflects visual acuity, showed a gradual decline through 10 months. Interestingly, female mice had more reduction in visual acuity than males. ERG assessment showed a gradual decline in scotopic and photopic responses in RhoP23H/+ mice. To investigate the neuroprotective benefits of Sig1R activation in the RhoP23H/+ mouse model, mutant mice were treated with a high-specificity Sig1R ligand (+)-pentazocine ((+)-PTZ) 3x/week at 0.5 mg/kg and examined using OMR, ERG, SD-OCT. A significant retention of visual function was observed in males and females at 10 months of age, with treated females retaining ∼50% greater visual acuity than non-treated mutant females. ERG revealed significant retention of scotopic and photopic b-wave amplitudes at 6 months in male and female RhoP23H/+ mice treated with (+)-PTZ. Further, in vivo analysis by SD-OCT revealed a significant retention of outer nuclear layer (ONL) thickness in male and female treated RhoP23H/+ mice. Histological studies showed significant retention of IS/OS length (∼50%), ONL thickness, and number of rows of photoreceptor cell nuclei at 6 months in (+)-PTZ-treated mutant mice. Interestingly, electron microscopy revealed preservation of OS discs in (+)-PTZ treated mutant mice compared to non-treated. Taken collectively, the in vivo and in vitro data provide the first evidence that targeting Sig1R can rescue visual function and structure in the RhoP23H/+ mouse. These results are promising and provide a framework for future studies to investigate Sig1R as a potential therapeutic target in retinal degenerative disease.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

109462

Journal (Volume, Issue Number)

Experimental eye research (Volume 230)

Publication milestones

  • Published - 05/2023

Publication status

Published - 05/2023

ISSN

0014-4835

Publication IDs

  • Scopus: 85151550792
  • PubMed: 37003581

Publication metrics

Metrics

Fractional count
3
Fractional count
0.43
Fractional count
4
Fractional count
0.57
Fractional count
3
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
9
Citation count
6

Funding Details

This work was supported by the National Institutes of Health (National Eye Institute, R01 EY012830 and P30 EY031631), and the James and Jean Culver Vision Discovery Institute of Augusta University. We acknowledge the EM/Histology Core (Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University) for the excellent instrumentation and technical assistance in tissue processing and EM imaging acquisition. This work was supported by the National Institutes of Health ( National Eye Institute , R01 EY012830 and P30 EY031631 ), and the James and Jean Culver Vision Discovery Institute of Augusta University . We acknowledge the EM/Histology Core (Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University) for the excellent instrumentation and technical assistance in tissue processing and EM imaging acquisition.
FundersFunding numbers
James and Jean Culver Vision Discovery Institute of Augusta University
-
NIH
-
NEI
R01 EY012830, P30 EY031631
Augusta University-